SLC16A1 and prostate cancer: In prostate cancer, lactate enters cancer cells through monocarboxylate transporter 1 (MCT1) and stabilizes hypoxia inducible factor 1 α (HIF1α) via lactylation, thereby inducing the HIF1α pathway to stimulate angiogenesis (Fig. 3b)60.